Position in MYGN
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$4,135,333
-$3,186,647 QoQ
Shares Held
918,963
-22.8% QoQ
Ownership
0.973%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MYGN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Nuveen, LLC holds $2,979,583,952 across 30 Diagnostics & Research names. MYGN ranks #25 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
5,334,755 | $1,011,469,546 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
1,646,989 | $809,544,502 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
445,804 | $250,492,808 | |
| 4 | A |
Agilent Technologies, Inc.
|
865,669 | $98,668,951 | |
| 5 | NTRA |
Natera, Inc.
|
474,608 | $94,916,853 | |
| 6 | DGX |
Quest Diagnostics Inc
|
465,425 | $91,213,989 | |
| 7 | MTD |
Mettler Toledo International Inc/
|
68,803 | $86,774,343 | |
| 8 | IQV |
Iqvia Holdings Inc.
|
494,490 | $84,330,323 |
All Filings in MYGN
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,135,333 | 918,963 | Shares | Defined | 2026-04-30 | |
| 2025-12-31 | $7,321,980 | 1,190,566 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $5,240,996 | 724,896 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $3,924,269 | 739,034 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $10,437,176 | 1,176,683 | Shares | Defined | 2025-05-12 | |
| No filing history on record for this holder in this stock. | ||||||